Skip to main content

Michael Richman

Equibles does not estimate personal net worth.

Get an email with a short summary when NextCure, Inc. publishes a filing, an earnings call transcript or a press release.

Get NXTC alerts

About Michael Richman

Michael Richman is recorded as CEO at NextCure, Inc. (NXTC). The newest filing on record that lists Michael Richman as CEO at NextCure, Inc. (NXTC) is dated April 24, 2026. The proxy statement of NextCure, Inc. reports total compensation of $941,692 for Michael Richman in fiscal 2025, including a base salary of $609,258. Disclosed compensation is on record for 8 fiscal years. NextCure, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at NextCure, Inc. includes Steven P. Cobourn (CFO), Timothy Mayer (COO), Kevin G. Shaw (General Counsel) and 4 others.

Affiliation history

Company network

Leadership on record at NextCure, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 NextCure, Inc. (NXTC) $609,258 $941,692
2024 NextCure, Inc. (NXTC) $591,483 $1,510,939
2023 NextCure, Inc. (NXTC) $571,875 $1,044,627
2022 NextCure, Inc. (NXTC) $549,375 $1,724,186
2021 NextCure, Inc. (NXTC) $529,167 $3,321,425
2020 NextCure, Inc. (NXTC) $490,969 $6,488,396
2019 NextCure, Inc. (NXTC) $418,534 $625,679
2018 NextCure, Inc. (NXTC) $383,400 $2,501,597

Recent activity

No call appearances or filed executive changes recorded yet.